Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction

Nature Medicine

Volumn 19, Issue 3, 2013, Pages 291-294

  Shi, Lihong ^a   Cui, Shuaiying ^a   Engel, James D ^a   Tanabe, Osamu ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; LYSINE SPECIFIC DEMETHYLASE 1; METHYLTRANSFERASE; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ERYTHROID CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

ANEMIA, SICKLE CELL; ANIMALS; BETA-GLOBINS; BETA-THALASSEMIA; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROID CELLS; FETAL HEMOGLOBIN; GAMMA-GLOBINS; HISTONE DEMETHYLASES; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; MONOAMINE OXIDASE INHIBITORS; NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; PROMOTER REGIONS, GENETIC; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANYLCYPROMINE;

MUS MUSCULUS;

EID: 84875230084     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3101     Document Type: Article

References (22)

1. Testa, U. Ann. Hematol. 88, 505-528 (2009).
2. Tanabe, O. et al. EMBO J. 21, 3434-3442 (2002).
3. Tanabe, O. et al. EMBO J. 26, 2295-2306 (2007).
4. Cui, S. et al. Mol. Cell Biol. 31, 3298-3311 (2011).
5. Shi, Y. et al. Cell 119, 941-953 (2004).
6. Hu, X. et al. Proc. Natl. Acad. Sci. USA 106, 10141-10146 (2009).
7. Saleque, S., Kim, J., Rooke, H.M. & Orkin, S.H. Mol. Cell 27, 562-572 (2007).
8. Lee, M.G., Wynder, C., Schmidt, D.M., McCafferty, D.G. & Shiekhattar, R. Chem. Biol. 13, 563-567 (2006).
9. Mallinger, A.G. & Smith, E. Psychopharmacol. Bull. 27, 493-502 (1991).
10. Wang, J. et al. Nat. Genet. 41, 125-129 (2009).
11. Moutouh-de Parseval, L.A. et al. J. Clin. Invest. 118, 248-258 (2008).
12. Banzon, V. et al. Exp. Hematol. 39, 26-36. e1 (2011).
13. Sankaran, V.G. et al. Nature 460, 1093-1097 (2009).
14. Buller, A.M., Elford, H.L., DuBois, C.C., Meyer, J. & Lloyd, J.A. Blood Cells Mol. Dis. 25, 255-269 (1999).
15. Xu, J. et al. Science 334, 993-996 (2011).
16. Menzel, S. et al. Nat. Genet. 39, 1197-1199 (2007).
17. Wilber, A., Nienhuis, A.W. & Persons, D.A. Blood 117, 3945-3953 (2011).
18. Frieling, H. & Bleich, S. Eur. Arch. Psychiatry Clin. Neurosci. 256, 268-273 (2006).
19. Sprüssel, A. et al. Leukemia 26, 2039-2051 (2012).
20. Eyer, F., Jetzinger, E., Pfab, R. & Zilker, T. Clin. Toxicol. (Phila.) 46, 261-263 (2008).
21. Giarratana, M.C. et al. Nat. Biotechnol. 23, 69-74 (2005).
22. Irizarry, R.A. et al. Biostatistics 4, 249-264 (2003).